| Delaware                                                              |   | 27-1994359                           |
|-----------------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization)        |   | (I.R.S. Employer Identification No.) |
|                                                                  |   |                                 |
| 2030 Marine Drive, Suite 302North Vancouver, British Columbia, Canada |   | V7P 1V7                              |
| (Address of principal executive offices)                              |   | (Zip Code)                           |

| None                |   | N/A                                       |
|---------------------|--------|-------------------------------------------|
| Title of each class |   | Name of each exchange on which registered |

----

| ●   | statements contained in Item 7 and the notes to our audited consolidated financial statements concerning our results of operations, financial condition and our ability to finance our business; |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | statements contained in Item 1 concerning our products, operations and compliance with applicable laws; and |
|---------------------|-------------------------------------------------------------------------------------------------------------|

| ●   | statements throughout this annual report concerning our legal structure, the regulation of our business and the market for our common stock. |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | risks related to government regulations and approvals of our products; |
|---------------------|------------------------------------------------------------------------|

| ●   | our need for additional capital to pursue our plan of operations; |
|---------------------|-------------------------------------------------------------------|

| ●   | our dependence on key personnel; and |
|---------------------|--------------------------------------|

| ●   | our ability to compete effectively with competitors that have greater financial, marketing and other resources. |
|---------------------|-----------------------------------------------------------------------------------------------------------------|

----

| PART I                                                                                                                           | 3      |
|----------------------------------------------------------------------------------------------------------------------------------|--------|
| Item 1.  Business                                                                                                           | 3      |
| Item 1A.  Risk Factors                                                                                                      | 8      |
| Item 1B.  Unresolved Staff Comments                                                                                         | 8      |
| Item 2.  Properties                                                                                                         | 8      |
| Item 3.  Legal Proceedings                                                                                                  | 8      |
| Item 4.  Mine Safety Disclosures                                                                                            | 8      |
|                                                                                                                             |   |
| PART II                                                                                                                          | 9      |
| Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 9      |
| Item 6.  Selected Financial Data                                                                                            | 10     |
| Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations                              | 11     |
| Item 7A.  Quantitative and Qualitative Disclosures about Market Risk                                                        | 14     |
| Item 8.  Financial Statements and Supplementary Data                                                                        | 15     |
| Item 9.  Changes In and Disagreements with Accountants on Accounting and Financial Disclosure                               | 16     |
| Item 9A.  Controls and Procedures                                                                                           | 16     |
| Item 9B.  Other Information                                                                                                 | 16     |
|                                                                                                                             |   |
| PART III                                                                                                                         | 17     |
| Item 10.  Directors, Executive Officers and Corporate Governance                                                            | 17     |
| Item 11.  Executive Compensation                                                                                            | 20     |
| Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters                    | 22     |
| Item 13.  Certain Relationships and Related Transactions, and Director Independence                                         | 23     |
| Item 14.  Principal Accounting Fees and Services                                                                            | 26     |
|                                                                                                                             |   |
| PART IV                                                                                                                          | 27     |
| Item 15.  Exhibits, Financial Statement Schedules                                                                           | 27     |
|                                                                                                                             |   |
| SIGNATURES                                                                                                                       | 28     |

----

PART I

Item 1.  Business

----

----

----

----

| ●   | The AQUAtapTM system not only purifies and stores the produced water, but also contains a distribution point for the end user. |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------|

| ●   | The AQUAtapTM system is configurable to the source water, thereby providing the option of either a reverse osmosis membrane (in the event of saline or brackish source water) or an ultrafiltration membrane (in the event of contaminated fresh source water). |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | The AQUAtapTM system has higher qualities as compared to our competitors’ for the specific markets that we are pursuing. For example, one competitor manufactures only a mobile disaster relief system that is cost prohibitive and not suitable for use in our target markets. Their units include redundant systems for their identified target market, rendering it cost inefficient. They also operate from grid or generator power and do not offer solar power as an option, further rendering their system unsuitable. Another competitor markets a large reverse osmosis system that is possibly suitable for larger markets or when greater amounts of water are required. It is not a suitable product for our target market in that it utilizes only reverse osmosis membranes, which, if the source water is contaminated fresh water, renders it somewhat excessive and too expensive. Purifying contaminated fresh water as opposed to saline water, reverse osmosis requires a greater amount of power to operate; hence a large array of solar panels is required, making the system far too expensive to operate, when an ultrafiltration membrane and a smaller array of solar panels would suffice to produce the same quantity of water. |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Item 1A.  Risk Factors

Item 1B.  Unresolved Staff Comments

Item 2.  Properties

Item 3.  Legal Proceedings

Item 4.  Mine Safety Disclosures

----

PART II

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

| OTC Bulletin Board / OTCQB |
|----------------------------|
| Quarter Ended              | High ($) | Low ($) |
| December 31, 2012          | 0.95 | 0.26 |
| September 30, 2012         | 1.60 | 0.54 |
| June 30, 2012              | 1.25 | 0.68 |
| March 31, 2012             | - | - |
| December 31, 2011          | - | - |
| September 30, 2011         | - | - |
| June 30, 2011              | - | - |
| March 31, 2011             | - | - |

----

Item 6.  Selected Financial Data

----

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

----

----

| Description                         |   | Amount($) |    |
|-------------------------------------|--------|-----------|---------|
| Equipment purchases                 |   |      | 10,000  |   |
| Rent                                |   |      | 30,000  |   |
| Management fees                     |   |      | 300,000 |   |
| Consulting fees                     |   |      | 150,000 |   |
| Professional fees                   |   |      | 130,000 |   |
| Advertising and promotion expenses  |   |      | 15,000  |   |
| Travel and automotive expenses      |   |      | 60,000  |   |
| General and administrative expenses |   |      | 50,000  |   |
| Total                               |   |      | 745,000 |   |

----

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

----

Item 8.  Financial Statements and Supplementary Data

| Report of Independent Registered Public Accounting Firm  | F-1    |
|---------------------------------------------------------------|--------|
|                                                          |   |
| Consolidated Balance Sheets                              | F-2    |
|                                                          |   |
| Consolidated Statements of Operations                    | F-3    |
|                                                          |   |
| Consolidated Statement of Stockholders’ Deficit    | F-4    |
|                                                          |   |
| Consolidated Statements of Cash Flows                    | F-5    |
|                                                          |   |
| Notes to the Consolidated Financial Statements           | F-7    |

----

----

|                                                                                                                                   |   | December 31,2012 |       |   | December 31,2011 |   |
|----------------------------------------------------------------------------------------------------------------------------------------|--------|------------------|------------|--------|------------------|--------|
|                                                                                                                                   |   | $                |       |   | $                |   |
|                                                                                                                                   |   |             |       |   |             |   |
| ASSETS                                                                                                                                 |   |             |       |   |             |   |
|                                                                                                                                   |   |             |       |   |             |   |
| Current assets                                                                                                                         |   |             |       |   |             |   |
|                                                                                                                                   |   |             |       |   |             |   |
| Cash                                                                                                                                   |   |             | 1,732      |   |             |   | 33,060 |   |
| Prepaid expenses                                                                                                                       |   |             | 7,835      |   |             |   | 12,429 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total current assets                                                                                                                   |   |             | 9,567      |   |             |   | 45,489 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Equipment (Note 3)                                                                                                                     |   |             | 275,343    |   |             |   | 275,712 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total assets                                                                                                                           |   |             | 284,910    |   |             |   | 321,201 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                            |   |             |       |   |             |   |   |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Current liabilities                                                                                                                    |   |             |       |   |             |   |   |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Accounts payable                                                                                                                       |   |             | 259,031    |   |             |   | 166,642 |   |
| Accrued liabilities                                                                                                                    |   |             | 9,098      |   |             |   | 29,158 |   |
| Convertible notes payable, net of unamortized discount of $5,914 (2011 - $16,693) (Note 4)                                             |   |             | 30,906     |   |             |   | 262,807 |   |
| Loan payable (Note 5)                                                                                                                  |   |             | –    |   |             |   | 200,000 |   |
| Due to related parties (Note 6)                                                                                                        |   |             | 502,082    |   |             |   | 515,893 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total current liabilities                                                                                                              |   |             | 801,117    |   |             |   | 1,174,500 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Convertible notes payable, net of unamortized discount of $79,792 (2011 - $nil) (Note 4)                                               |   |             | 95,208     |   |             |   | – |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total liabilities                                                                                                                      |   |             | 896,325    |   |             |   | 1,174,500 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Nature of operations and continuance of business (Note 1)                                                                              |   |             |       |   |             |   |   |   |
| Commitments (Note 10)                                                                                                                  |   |             |       |   |             |   |   |   |
| Subsequent events (Note 12)                                                                                                            |   |             |       |   |             |   |   |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Stockholders’ deficit                                                                                                            |   |             |       |   |             |   |   |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Preferred stock, 5,000,000 shares authorized, $0.000001 par value, 2 and nil shares issued and outstanding, respectively               |   |             | 1          |   |             |   | – |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Common stock, 95,000,000 shares authorized, $0.000001 par value, 84,833,860 and 49,114,666 shares issued and outstanding, respectively |   |             | 5,139      |   |             |   | 4,911 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Additional paid-in capital                                                                                                             |   |             | 4,479,410  |   |             |   | 590,207 |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Common stock issuable                                                                                                                  |   |             | 168,000    |   |             |   | – |   |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Deficit accumulated during the development stage                                                                                       |   |             | (5,263,965 | )      |             |   | (1,448,417 | ) |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total stockholders’ deficit                                                                                                      |   |             | (611,415   | )      |             |   | (853,299 | ) |
|                                                                                                                                   |   |             |       |   |             |   |   |   |
| Total liabilities and stockholders’ deficit                                                                                      |   |             | 284,910    |   |             |   | 321,201 |   |

----

|                                                             |   |  Year endedDecember 31,2012$ |       |   |   Year endedDecember 31,2011$ |   |       | Accumulated from February 20, 2009 (date of inception) to December 31,2012$ |   |
|------------------------------------------------------------------|--------|-----------------------------------|------------|--------|-----------------------------------------|--------|------------|-----------------------------------------------------------------------------|--------|
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |
| Revenue                                                          |   |                              | –    |   |                                    |   | –    |                                                                        |   |   | – |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Expenses                                                         |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Advertising and promotion                                        |   |                              | 45,218     |   |                                    |   | 7,446      |                                                                        |   |   | 62,373 |   |
| Amortization                                                     |   |                              | 64,465     |   |                                    |   | 4,048      |                                                                        |   |   | 74,489 |   |
| Automotive                                                       |   |                              | 41,395     |   |                                    |   | 20,909     |                                                                        |   |   | 79,730 |   |
| Consulting fees (Note 9)                                         |   |                              | 919,486    |   |                                    |   | 56,533     |                                                                        |   |   | 1,087,009 |   |
| Foreign exchange loss (gain)                                     |   |                              | 14,339     |   |                                    |   | (14,171    | )                                                                           |   |   | 2,671 |   |
| Management fees (Notes 6 and 9)                                  |   |                              | 2,239,525  |   |                                    |   | 200,000    |                                                                        |   |   | 2,799,525 |   |
| Office and miscellaneous                                         |   |                              | 35,842     |   |                                    |   | 16,798     |                                                                        |   |   | 88,806 |   |
| Professional fees                                                |   |                              | 284,088    |   |                                    |   | 149,676    |                                                                        |   |   | 558,447 |   |
| Rent                                                             |   |                              | 30,337     |   |                                    |   | 30,653     |                                                                        |   |   | 116,380 |   |
| Telephone                                                        |   |                              | 13,745     |   |                                    |   | 10,955     |                                                                        |   |   | 50,055 |   |
| Transfer agent and filing fees                                   |   |                              | 16,500     |   |                                    |   | –    |                                                                        |   |   | 16,500 |   |
| Travel                                                           |   |                              | 54,966     |   |                                    |   | 3,197      |                                                                        |   |   | 160,922 |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
|                                                             |   |                              | 3,759,906  |   |                                    |   | 486,044    |                                                                        |   |   | 5,096,907 |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Loss before other income (expense)                               |   |                              | (3,759,906 | )      |                                    |   | (486,044   | )                                                                           |   |   | (5,096,907 | ) |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Other income (expense)                                           |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Accretion of discount on convertible notes payable               |   |                              | (55,463    | )      |                                    |   | (109,331   | )                                                                           |   |   | (169,650 | ) |
| Gain on settlement of debt                                       |   |                              | –    |   |                                    |   | –    |                                                                        |   |   | 7,723 |   |
| Interest expense                                                 |   |                              | (179       | )      |                                    |   | (4         | )                                                                           |   |   | (6,206 | ) |
| Interest income                                                  |   |                              | –    |   |                                    |   | –    |                                                                        |   |   | 1,075 |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
|                                                             |   |                              | (55,642    | )      |                                    |   | (109,335   | )                                                                           |   |   | (167,058 | ) |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Net loss                                                         |   |                              | (3,815,548 | )      |                                    |   | (595,379   | )                                                                           |   |   | (5,263,965 | ) |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Net loss per share, basic and diluted                            |   |                              | (0.05      | )      |                                    |   | (0.03      | )                                                                           |   |   |   |   |
|                                                             |   |                              |       |   |                                    |   |       |                                                                        |   |   |   |   |
| Weighted average number of shares outstanding, basic and diluted |   |                              | 83,669,358 |   |                                    |   | 23,572,886 |                                                                        |   |   |   |   |

----

|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    | Deficit     |   |   |    |   |
|---------------------------------------------------------------------------|--------|-----------------|---------|--------|--------------|--------|---------|---------|--------|--------|------------|--------|--------|-------------|---------|--------|-----------|--------|---------|-------------|--------|--------|---------|--------|
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    | accumulated |   |   |    |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   | Additional  |    |   | Common    |   |    | during the  |   |   |    |   |
|                                                                      |   | Preferred stock |    |   | Common stock |   |    | paid-in |   |   | stock      |   |   | development |    |   |      |   |
|                                                                      |   | Number          |    |   | Amount$      |   |    | Number  |   |   | Amount$    |   |   | capital$    |    |   | issuable$ |   |    | stage$      |   |   | Total$  |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |
| Balance, February 20, 2009 (date of inception)                            |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | – |        |   |   | – |   |   |   | – |   |   |   | – |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.0001 per share                         |   |            | – |   |         |   | – |    |   |   | 48,832,000 |   |   |        | 4,883   |   |      |   | (2,441  | )           |   |   | – |   |   |   | – |   |   |   | 2,442 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Net loss for the period                                                   |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | – |        |   |   | – |   |   |   | (545,892 | ) |   |   | (545,892 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Balance, December 31, 2009                                                |   |            | – |   |         |   | – |    |   |   | 48,832,000 |   |   |        | 4,883   |   |      |   | (2,441  | )           |   |   | – |   |   |   | (545,892 | ) |   |   | (543,450 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.25 per share                           |   |            | – |   |         |   | – |    |   |   | 160,000    |   |   |        | 16      |   |      |   | 19,984  |        |   |   | – |   |   |   | – |   |   |   | 20,000 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued to settle debt                                        |   |            | – |   |         |   | – |    |   |   | 126,000    |   |   |        | 13      |   |      |   | 15,737  |        |   |   | – |   |   |   | – |   |   |   | 15,750 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Share subscriptions received                                              |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | – |        |   |   | 10,000  |   |   |   | – |   |   |   | 10,000 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Fair value of beneficial conversion feature for convertible note payable  |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | 33,333  |        |   |   | – |   |   |   | – |   |   |   | 33,333 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Net loss for the year                                                     |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | – |        |   |   | – |   |   |   | (307,146 | ) |   |   | (307,146 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Balance, December 31, 2010                                                |   |            | – |   |         |   | – |    |   |   | 49,118,000 |   |   |        | 4,912   |   |      |   | 66,613  |        |   |   | 10,000  |   |   |   | (853,038 | ) |   |   | (771,513 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.25 per share                           |   |            | – |   |         |   | – |    |   |   | 2,440,000  |   |   |        | 244     |   |      |   | 304,756 |        |   |   | (10,000 | )      |   |   | – |   |   |   | 295,000 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.20 per share                           |   |            | – |   |         |   | – |    |   |   | 200,000    |   |   |        | 20      |   |      |   | 19,980  |        |   |   | – |   |   |   | – |   |   |   | 20,000 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock cancelled                                                    |   |            | – |   |         |   | – |    |   |   | (4,010,000 | )      |   |        | (401    | )      |      |   | 200     |        |   |   | – |   |   |   | – |   |   |   | (201 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for conversion of notes payable                       |   |            | – |   |         |   | – |    |   |   | 1,366,666  |   |   |        | 136     |   |      |   | 99,864  |        |   |   |    |   |   |   |   |   |   |   | 100,000 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Fair value of beneficial conversion feature for convertible notes payable |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | 98,794  |        |   |   | – |   |   |   | – |   |   |   | 98,794 |   |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Net loss for the year                                                     |   |            | – |   |         |   | – |    |   |   | –    |   |   |        | – |   |      |   | – |        |   |   | – |   |   |   | (595,379 | ) |   |   | (595,379 | ) |
|                                                                      |   |            |    |   |         |   |    |    |   |   |       |   |   |        |    |   |      |   |    |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Balance, December 31, 2011                                                |   |            | – |   |         |   | – |    |   |   | 49,114,666 |   |   |        | 4,911   |   |      |   | 590,207 |        |   |   | – |   |   |   | (1,448,417 | ) |   |   | (853,299 | ) |

----

|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      | Deficit     |   |   |    |   |
|-------------------------------------------------------------------------------|--------|-----------------|---------|--------|--------------|--------|---------|--------------|--------|--------|-------------|--------|--------|-------------|---------|--------|-----------|--------|-----------|-------------|--------|--------|---------|--------|
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      | accumulated |   |   |    |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   | Additional  |    |   | Common    |   |      | during the  |   |   |    |   |
|                                                                          |   | Preferred stock |    |   | Common stock |   |    | paid-in      |   |   | stock       |   |   | development |    |   |      |   |
|                                                                          |   | Number     |    |   | Amount$      |   |    | Number  |   |   | Amount$     |   |   | capital$    |    |   | issuable$ |   |      | stage$      |   |   | Total$  |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |
| Balance, December 31, 2011                                                    |   |            | – |   |         |   | – |         |   |   | 49,114,666  |   |   |        | 4,911   |   |      |   | 590,207   |        |   |   | – |   |   |   | (1,448,417 | ) |   |   | (853,299 | ) |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Fair value of beneficial conversion feature for convertible notes payable     |   |            | – |   |         |   | – |         |   |   | –     |   |   |        | – |   |      |   | 3,226     |        |   |   | – |   |   |   | – |   |   |   | 3,226 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Conversion of debt                                                            |   |            | – |   |         |   | – |         |   |   | 2,255,194   |   |   |        | 225     |   |      |   | 225,275   |        |   |   | – |   |   |   | – |   |   |   | 225,500 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| January 6, 2012 – recapitalization transactions:                        |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Shares of Quest Water Global, Inc.                                            |   |            | – |   |         |   | – |         |   |   | 110,500,000 |   |   |        | 111     |   |      |   | 80,389    |        |   |   | – |   |   |   | (87,291 | ) |   |   | (6,791 | ) |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Preferred stock issued                                                        |   |            | 2       |   |         |   | 1       |         |   |   | –     |   |   |        | – |   |      |   | –   |        |   |   | – |   |   |   | – |   |   |   | 1 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock returned and cancelled for spin out of RPM Dental, Inc. (Note 1) |   |            | – |   |         |   | – |         |   |   | (80,000,000 | )      |   |        | (80     | )      |      |   | 49,920    | )           |   |   | – |   |   |   | 56,791 |   |   |   | 6,791 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common share issued for Quest (Note 1)                                        |   |            | – |   |         |   | – |         |   |   | 51,369,860  |   |   |        | – |   |      |   | –   |        |   |   | – |   |   |   | – |   |   |   | – |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Recapitalization                                                              |   |            | – |   |         |   | – |         |   |   | (51,369,860 | )      |   |        | (32     | )      |      |   | (30,368   | )           |   |   | – |   |   |   | 30,500 |   |   |   | – |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.25 per share                               |   |            | – |   |         |   | – |         |   |   | 2,398,000   |   |   |        | 2       |   |      |   | 599,498   |        |   |   | – |   |   |   | – |   |   |   | 599,500 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for cash at $0.25 per share                               |   |            | – |   |         |   | – |         |   |   | 310,000     |   |   |        | 1       |   |      |   | 77,499    |        |   |   | – |   |   |   | – |   |   |   | 77,500 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issued for conversion of notes payable                           |   |            | – |   |         |   | – |         |   |   | 256,000     |   |   |        | 1       |   |      |   | 63,999    |        |   |   | – |   |   |   |   |   |   |   | 64,000 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Stock-based compensation                                                      |   |            | – |   |         |   | – |         |   |   | –     |   |   |        | – |   |      |   | 2,798,455 |        |   |   | – |   |   |   | – |   |   |   | 2,798,455 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Fair value of beneficial conversion feature for convertible notes payable     |   |            | – |   |         |   | – |         |   |   | –     |   |   |        | – |   |      |   | 121,250   |        |   |   | – |   |   |   | – |   |   |   | 121,250 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Common stock issuable                                                         |   |            | – |   |         |   | – |         |   |   | –     |   |   |        | – |   |      |   | –   |        |   |   | 168,000 |   |   |   | – |   |   |   | 168,000 |   |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Net loss for the year                                                         |   |            | – |   |         |   | – |         |   |   | –     |   |   |        | – |   |      |   | –   |        |   |   | – |   |   |   | (3,815,548 | ) |   |   | (3,815,548 | ) |
|                                                                          |   |            |    |   |         |   |    |         |   |   |        |   |   |        |    |   |      |   |      |        |   |   |    |   |   |   |   |   |   |   |   |   |
| Balance, December 31, 2012                                                    |   |            | 2       |   |         |   | 1       |         |   |   | 84,833,860  |   |   |        | 5,139   |   |      |   | 4,479,410 |        |   |   | 168,000 |   |   |   | (5,263,965 | ) |   |   | (611,645 | ) |

----

|                                                                                              |   |   Year endedDecember 31,2012$ |       |   |   Year endedDecember 31,2011$ |   |     | Accumulated from February 20, 2009 (date of inception) to December 31,2012$ |   |
|---------------------------------------------------------------------------------------------------|--------|-----------------------------------------|------------|--------|-----------------------------------------|--------|----------|-----------------------------------------------------------------------------|--------|
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |
| Operating Activities:                                                                             |   |                                    |       |   |                                    |   |     |                                                                        |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |
| Net loss for the period                                                                           |   |                                    | (3,815,548 | )      |                                    |   | (595,379 | )                                                                           |   |   | (5,362,965 | ) |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Adjustments to reconcile net loss to net cash used in operating activities:                       |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Accretion of discount on convertible note payable                                                 |   |                                    | 55,463     |   |                                    |   | 109,331  |                                                                        |   |   | 169,650 |   |
| Amortization                                                                                      |   |                                    | 64,465     |   |                                    |   | 4,048    |                                                                        |   |   | 74,489 |   |
| Gain on settlement of debt                                                                        |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | (7,902 | ) |
| Stock-based compensation                                                                          |   |                                    | 2,798,455  |   |                                    |   | –  |                                                                        |   |   | 2,798,455 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Changes in operating assets and liabilities:                                                      |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Prepaid expenses                                                                                  |   |                                    | 4,594      |   |                                    |   | 7,571    |                                                                        |   |   | (7,835 | ) |
| Accounts payable                                                                                  |   |                                    | 92,389     |   |                                    |   | 51,704   |                                                                        |   |   | 274,683 |   |
| Accrued liabilities                                                                               |   |                                    | (20,060    | )      |                                    |   | 20,158   |                                                                        |   |   | 10,345 |   |
| Due to/from related parties                                                                       |   |                                    | (13,810    | )      |                                    |   | 52,883   |                                                                        |   |   | 501,882 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Net cash used in operating activities                                                             |   |                                    | (834,052   | )      |                                    |   | (349,684 | )                                                                           |   |   | (1,450,198 | ) |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Investing Activities:                                                                             |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Purchase of property and equipment                                                                |   |                                    | (64,096    | )      |                                    |   | (272,832 | )                                                                           |   |   | (349,832 | ) |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Net cash used in investing activities                                                             |   |                                    | (64,096    | )      |                                    |   | (272,832 | )                                                                           |   |   | (349,832 | ) |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Financing Activities:                                                                             |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Proceeds from convertible notes payable                                                           |   |                                    | 221,820    |   |                                    |   | 329,500  |                                                                        |   |   | 601,320 |   |
| Proceeds from loans payable                                                                       |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | 208,000 |   |
| Repayment of loans payable                                                                        |   |                                    | (200,000   | )      |                                    |   | –  |                                                                        |   |   | (200,000 | ) |
| Proceeds from issuance of common stock                                                            |   |                                    | 845,000    |   |                                    |   | 315,000  |                                                                        |   |   | 1,192,442 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Net cash provided by financing activities                                                         |   |                                    | 866,820    |   |                                    |   | 644,500  |                                                                        |   |   | 1,801,762 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Increase (decrease) in cash                                                                       |   |                                    | (31,328    | )      |                                    |   | 21,984   |                                                                        |   |   | 1,732 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Cash, beginning of year                                                                           |   |                                    | 33,060     |   |                                    |   | 11,076   |                                                                        |   |   | – |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Cash, end of year                                                                                 |   |                                    | 1,732      |   |                                    |   | 33,060   |                                                                        |   |   | 1,732 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Non-cash investing and financing activities:                                                      |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Common stock issued to settle accounts payable                                                    |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | 11,750 |   |
| Quest notes conversion to common stock prior to recapitalization transaction (Notes 4(a) and (b)) |   |                                    | 225,500    |   |                                    |   | 100,000  |                                                                        |   |   | 325,500 |   |
| Common stock issued pursuant to the conversion of notes payable                                   |   |                                    | 64,000     |   |                                    |   | –  |                                                                        |   |   | 64,000 |   |
| Common stock issued to settle loans payable                                                       |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | 4,000 |   |
|                                                                                              |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Supplemental disclosures:                                                                         |   |                                    |       |   |                                    |   |     |                                                                        |   |   |   |   |
| Interest paid                                                                                     |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | 1,586 |   |
| Income tax paid                                                                                   |   |                                    | –    |   |                                    |   | –  |                                                                        |   |   | – |   |

----

| ● | Acquisition of Quest. The Company acquired all of the outstanding capital stock of Quest in exchange for the issuance of 51,369,860 shares of the Company’s common stock pursuant to a Share Exchange Agreement between the Company, the Company’s former principal stockholder, Quest and the former stockholders of Quest. As a result of this transaction, Quest became the Company’s wholly owned subsidiary and the former shareholders of Quest became the Company’s controlling stockholders. The transaction was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Quest is considered the acquirer for accounting and financial reporting purposes. Accordingly, the comparative financial statements, including the disclosures from inception, are that of Quest. |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Two former shareholders of Quest each received one share of the Company’s newly designated Series A Voting Preferred Stock. Each share of Series A Voting Preferred Stock entitles the holder thereof to the number of votes equal to the quotient derived by dividing the total number of outstanding shares of Series A Voting Prefered Stock into a number equal to quotient derived by dividing 0.4285 into the total number of votes of the common stock and any other capital stock of the Company. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ● | Spin-Out of RPM Dental Business. Immediately prior to the acquisition of Quest, the Company spun-out RPM Dental Systems, LLC, a limited liability company formed in Kentucky and a wholly owned subsidiary, to the Company’s former officer and director and principal stockholder. As consideration the former director returned 80,000,000 shares of the Company’s common stock held by that person. These shares were cancelled immediately following the acquisition. |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ● | Financing Transaction. Immediately following the acquisition of Quest, the Company completed a private offering of units consisting of an aggregate of (i) 2,398,000 shares of common stock and (ii) warrants to purchase 2,398,000 shares of common stock. The warrants have a three-year term and a per share exercise price of $0.50. The aggregate purchase price of the units was $599,500. |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (a)  | Basic of Presentation and Consolidation |
|-----------|-----------------------------------------|

| (b)  | Use of Estimates |
|-----------|------------------|

| (c)  | Equipment |
|-----------|-----------|

| Computer equipment                    | 45%  | declining balance basis |
|---------------------------------------|------|-------------------------|
| Computer software                     | 100% | declining balance basis |
| Demonstration equipment and furniture | 20%  | declining balance basis |

| (d)  | Long-lived Assets |
|-----------|-------------------|

----

| (e)  | Financial Instruments and Fair Value Measures |
|-----------|-----------------------------------------------|

| (f)  | Loss Per Share |
|-----------|----------------|

| (g)  | Comprehensive Loss |
|-----------|--------------------|

| (h)  | Reclassifications |
|-----------|-------------------|

----

| (i)  | Foreign Currency Translation |
|-----------|------------------------------|

| (j)  | Income Taxes |
|-----------|--------------|

| (k)  | Recent Accounting Pronouncements |
|-----------|----------------------------------|

|                    |   | Cost   |    |   |   Accumulated Amortization |   |   | Net CarryingValueDecember 31,2012 |   |   | Net CarryingValueDecember 31,2011 |   |
|-------------------------|--------|--------|---------|--------|--------------------------------------|--------|--------|-----------------------------------|--------|--------|-----------------------------------|--------|
|                    |   |   |    |   |                                 |   |   |                              |   |   |                              |   |
| Computer equipment      |   |   | 25,971  |   |                                 |   | 11,980 |                              |   |   | 13,991                            |   |   |   | 4,853 |   |
| Computer software       |   |   | 1,673   |   |                                 |   | 1,673  |                              |   |   | –                           |   |   |   | – |   |
| Demonstration equipment |   |   | 314,762 |   |                                 |   | 57,877 |                              |   |   | 256,885                           |   |   |   | 265,275 |   |
| Equipment               |   |   | 7,426   |   |                                 |   | 2,959  |                              |   |   | 4,467                             |   |   |   | 5,584 |   |
|                    |   |   |    |   |                                 |   |   |                              |   |   |                              |   |   |   |   |   |
|                    |   |   | 349,832 |   |                                 |   | 74,489 |                              |   |   | 275,343                           |   |   |   | 275,712 |   |

----

| (a)  | On September 11, 2011, Quest received proceeds of $200,000 and issued a convertible promissory note for $200,000, which bears interest at 10% per annum, is unsecured, and due on demand. The unpaid amount of principal and accrued interest can be converted at any time at the holder’s option at $0.20 per share of common stock. In accordance with ASC 470-20, “Debt with Conversion and Other Options” (“ASC 470-20”), the Company recognized the intrinsic value of the embedded beneficial conversion feature of $50,000 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note up to its face value of $200,000. As at December 31, 2012, $50,000 has been accreted increasing the carrying value of the convertible note to $200,000. On January 5, 2012, Quest issued 2,000,000 shares of common stock pursuant to the conversion of the $200,000 note. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)  | On October 3, 2011, Quest received proceeds of $25,500 and issued three separate convertible notes which are non-interest bearing, unsecured, and due on demand. The unpaid amount can be converted at any time at the holders’ option at $0.20 per share of common stock. In accordance with ASC 470-20, Quest recognized the intrinsic value of the embedded beneficial conversion feature of $6,375 as additional paid-in capital and charged to operations over the term of the convertible notes up to their face value of $25,500. For the period ended December 31, 2011, $6,375 had been accreted, increasing the carrying value of the convertible notes to $25,500. On January 5, 2012, Quest issued 255,000 shares of common stock pursuant to the conversion of the $25,500 note. |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)  | During December 2011, Quest received proceeds of $54,000 and issued three separate convertible notes which are non-interest bearing, unsecured, and due on demand. The unpaid amount can be converted at any time at the holders’ option at $0.25 per unit. Each unit includes one share of common stock of the Company and one three-year share purchase warrant with an exercise price of $0.50. In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature of $17,419 as additional paid-in capital and charged to operations over the term of the convertible notes to accrete to their face value of $54,000. As at March 31, 2012, $5,081 had been accreted, increasing the carrying value of the convertible notes to $41,662. On May 4, 2012, the Company issued 216,000 shares of common stock pursuant to the conversion of the note; $12,338 had been accreted, increasing the carrying value of the convertible notes to $54,000 prior to conversion. |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (d)  | On January 3, 2012, Quest received proceeds of $10,000 and issued a convertible note which is non-interest bearing, unsecured, and due on demand. The unpaid amount can be converted at any time at the holder’s option at $0.25 per unit. Each unit includes one share of common stock of the Company and one three-year share purchase warrant with an exercise price of $0.50. In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature of $3,226 as additional paid-in capital and charged to operations over the term of the convertible notes to accrete to their face value of $10,000. As at March 31, 2012, $807 had been accreted, increasing the carrying value of the convertible note to $7,581. On May 4, 2012, the Company issued 40,000 shares of common stock pursuant to the conversion of the note; $2,419 had been accreted, increasing the carrying value of the convertible note to $10,000 prior to conversion. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (e)  | On May 9, 2012, the Company received proceeds of $150,000 and issued a convertible note which is non-interest bearing, unsecured, and due on May 9, 2014. The unpaid amount can be converted at any time at the holder’s option at $0.50 per share of common stock, which must not be less than $25,000 of unpaid principal. In accordance with ASC 470-20, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $90,000 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note up to its face value of $150,000. During the period ended December 31, 2012, $60,000 had been accreted, increasing the carrying value to $90,000. |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (f)  | On July 30, 2012, the Company received proceeds of $25,000 and issued a convertible note which is non-interest bearing, unsecured, and due on July 30, 2014. The unpaid amount can be converted at any time at the holder’s option at $0.50 per share of common stock. In accordance with ASC 470-20, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $25,000 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note up to its face value of $25,000. For the period ended December 31, 2012, $5,208 had been accreted, increasing the carrying value to $5,208. |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| (g)  | On December 11, 2012, the Company received proceeds of $25,000 and issued a convertible note which bears interest at 10% per annum, is unsecured, and due on December 11, 2013. The unpaid amount can be converted six months after the date of issuance at the holder’s option at $0.40 per share of common stock. In accordance with ASC 470-20, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $6,250 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note up to its face value of $25,000. For the period ended December 31, 2012, $336 had been accreted, increasing the carrying value to $19,086. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (h)  | On December 18, 2012, the Company received proceeds of $11,820 and issued a convertible note which bears interest at 10% per annum, is unsecured, and due on December 11, 2013. The unpaid amount can be converted six months after the date of issuance at the holder’s option at $0.40 per share of common stock. In accordance with ASC 470-20, the Company determined there is no embedded beneficial conversion feature. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (a)  | As at December 31, 2012, a total of $182,191 (December 31, 2011 - $302,421) is owed to the President of the Company, which is non-interest bearing, unsecured, and due on demand. |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)  | As at December 31, 2012, a total of $319,891 (December 31, 2011 - $213,472) is owed to the Vice President of the Company, which is non-interest bearing, unsecured, and due on demand. |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)  | For the year ended December 31, 2012, the Company incurred a total of $300,000 (2011 - $200,000) in management fees to the President and the Vice President of the Company. The Company also incurred stock-based compensation of $1,939,525 for stock options granted to the President and the Vice President of the Company during the year ended December 31, 2012, which is included in management fees. |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (a)  | On January 5, 2012, Quest issued 2,025,500 shares of common stock pursuant to the conversion of $225,500 in notes payable. Refer to Notes 4(a) and (b). |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)  | On January 6, 2012, the Company issued 51,369,860 shares of common stock for the acquisition of Quest. |
|-----------|--------------------------------------------------------------------------------------------------------|

| (c)  | On January 6, 2012, the Company issued 2,398,000 units at a price of $0.25 per unit for proceeds of $599,500. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.50 per share expiring on January 6, 2015. |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (d)  | On February 10, 2012, the Company issued 310,000 units at a price of $0.25 per unit for proceeds of $77,500. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.50 per share expiring on February 10, 2015. |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (e)  | On February 20, 2012, the Company completed a 20 for 1 forward split of its common stock. All share amounts have been retroactively adjusted for all periods presented. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (f)  | On May 4, 2012, the Company issued 216,000 shares of common stock at $0.25 per share pursuant to the conversion of the $54,000 note payable. Refer to Note 4(c). |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (g)  | On May 4, 2012, the Company issued 40,000 shares of common stock at $0.25 per share pursuant to the conversion of the $10,000 note payable. Refer to Note 4(d). |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (h)  | As at December 31, 2012, the Company had received share subscriptions of $168,000. Refer to Notes 12(a) and (b). |
|-----------|------------------------------------------------------------------------------------------------------------------|

----

|                                |   | Number ofwarrants  |      |   | Weighted average exercise price$ |   |
|-------------------------------------|--------|-------------------------|-----------|--------|----------------------------------|--------|
|                                |   |                    |      |   |                             |   |
| Balance, December 31, 2010 and 2011 |   |                    | –   |   |                             |   | – |   |
|                                |   |                    |      |   |                             |   |   |   |
| Issued                              |   |                    | 2,708,000 |   |                             |   | 0.50 |   |
|                                |   |                    |      |   |                             |   |   |   |
| Balance, December 31, 2012          |   |                    | 2,708,000 |   |                             |   | 0.50 |   |

| Number of warrants outstanding  | Exercise price$ |   Expiry date  |
|--------------------------------------|-----------------|-------------------------------|
|                                 |            |                          |
| 2,398,000                            | 0.50            | January 6, 2015               |
| 310,000                              | 0.50            | February 10, 2015             |
|                                 |            |                          |
| 2,708,000                            |            |                          |

|                                    |   | Numberof options  |      |   | Weightedaverageexercise price$ |   |
|-----------------------------------------|--------|------------------------|-----------|--------|--------------------------------|--------|
|                                    |   |                   |      |   |                           |   |
| Outstanding, December 31, 2010 and 2011 |   |                   | –   |   |                           |   | – |   |
|                                    |   |                   |      |   |                           |   |   |   |
| Granted                                 |   |                   | 5,050,000 |   |                           |   | 0.90 |   |
|                                    |   |                   |      |   |                           |   |   |   |
| Outstanding, December 31, 2012          |   |                   | 5,050,000 |   |                           |   | 0.90 |   |

|                     | Outstanding and exercisable |
|--------------------------|-----------------------------|
| Range ofexercise prices$ | Number of shares       | Weighted average remaining contractual life (years) | Weighted averageexercise price$ |
|                     |                        |   |   |
| 0.90                     | 5,050,000                   | 2.4 | 0.90 |

----

| (a)  | In January 2011, the Company signed a lease for office premises and agreed to pay annual basic rent of $12,024 plus taxes up to January 2014. |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------|

| (b)  | On November 1, 2011, the Company entered into a management agreement with the President of the Company whereby it is obligated to pay $12,500 per month starting on October 3, 2011 to November 1, 2016. |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The agreement may be terminated by written notice. Upon termination, the President shall receive a termination fee equal to the sum of: |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------|

| (i)     | Buy-out of any outstanding stock options for a price equal to the fair market value of the Company’s common stock multiplied by the number of shares under options and less the exercise price; plus |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (ii)     | The greater of: |
|-------------------------|-----------------|

| ●   |    The aggregate remaining fees for the unexpired remainder of the term; or |
|---------------------|--------------------------------------------------------------------------------------------|

| ●   |    One annual fee plus one month fee for each year served after November 1, 2011. |
|---------------------|--------------------------------------------------------------------------------------------------|

| (c)  | On November 1, 2011, the Company entered into a management agreement with the Vice-President of the Company whereby it is obligated to pay $12,500 per month starting on October 3, 2011 to November 1, 2016. |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The agreement may be terminated by written notice. Upon termination, the Vice-President shall receive a termination fee equal to the sum of: |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------|

| (i)     | Buy-out of any outstanding stock options for a price equal to the fair market value of the Company’s common stock multiplied by the number of shares under options and less the exercise price; p |
|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (ii)    | The greater of: |
|------------------------|-----------------|

| ●   |    The aggregate remaining fees for the unexpired remainder of the term; or |
|---------------------|--------------------------------------------------------------------------------------------|

| ●   |    One annual fee plus one month fee for each year served after November 1, 2011. |
|---------------------|--------------------------------------------------------------------------------------------------|

|                                  |   | 2012$  |      |   | 2011$  |   |
|---------------------------------------|--------|--------|-----------|--------|--------|--------|
|                                  |   |   |      |   |   |   |
| Income tax recovery at statutory rate |   |   | 1,297,283 |   |   |   | 201,143 |   |
|                                  |   |   |      |   |   |   |   |   |
| Permanent differences                 |   |   | (970,329  | )      |   |   | (37,349 | ) |
| Change in enacted tax rates           |   |   | –   |   |   |   | (43,358 | ) |
| Valuation allowance change            |   |   | (326,954  | )      |   |   | (120,436 | ) |
|                                  |   |   |      |   |   |   |   |   |
| Provision for income taxes            |   |   | –   |   |   |   | – |   |

|                                 |   | 2012$  |     |   | 2011$  |   |
|--------------------------------------|--------|--------|----------|--------|--------|--------|
|                                 |   |   |     |   |   |   |
| Net operating losses carried forward |   |   | 779,130  |   |   |   | 452,176 |   |
|                                 |   |   |     |   |   |   |   |   |
| Valuation allowance                  |   |   | (779,130 | )      |   |   | (452,176 | ) |
|                                 |   |   |     |   |   |   |   |   |
| Net deferred income tax asset        |   |   | –  |   |   |   | – |   |

----

| (a)  | On January 18, 2013, the Company issued 286,000 units at a price of $0.50 per unit for proceeds of $143,000, which was included in common stock issuable as at December 31, 2012. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.75 per share expiring on July 15, 2015. |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)  | On February 21, 2013, the Company issued 62,500 units at a price of $0.40 per unit for proceeds of $25,000, which was included in common stock issuable as at December 31, 2012. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $0.65 per share expiring on October 15, 2015. |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Item 9.  Changes In and Disagreements With Accountants on Accounting and Financial Disclosure

Item 9A.  Controls and Procedures

----

PART III

Item 10.  Directors, Executive Officers and Corporate Governance

| Name         | Age | Position                                                     |
|--------------|-----|--------------------------------------------------------------|
| John Balanko | 53  | Chairman, President, Chief Executive Officer, Director       |
| Peter Miele  | 54  | Vice President, Chief Financial Officer, Secretary, Director |

----

| ●   | any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated any federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated; |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | being the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of any law or regulation prohibiting mail or wire fraud or fraud in connection with any business activity; |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | being the subject of, or a party to, any judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state securities or commodities law or regulation or any law or regulation respecting financial institutions or insurance companies; or |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | being the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any stock, commodities or derivatives exchange or other self-regulatory organization. |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

Item 11.  Executive Compensation

| Summary Compensation Table                |
|-------------------------------------------|
| Name and Principal Position               | Year ended December 31 | Salary($) | Option Awards($) (1) | Total($) |
| John Balanko, Chief Executive Officer (2) | 2012 | 150,000 | 969,763 (3) | 1,119,763 |
| 2011                                      | 100,000 | - | 100,000 |
| Peter Miele, Chief Financial Officer (4)  | 2012 | 150,000 |  969,763 (3) | 1,119,763 |
| 2011                                      | 100,000 | - | 100,000 |

| (1) | See Note 9 of the notes to our audited consolidated financial statements included in this annual report for a description of the assumptions made in the valuation of option awards. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | John Balanko was appointed as our Chairman, President, Chief Executive Officer and director on January 6, 2012 and has served as the Chairman, President and Chief Executive Officer of Quest since the company’s inception in October 2008. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Represents stock-based compensation related to options vesting during the year ended December 31, 2012. |
|-----|---------------------------------------------------------------------------------------------------------|

| (4) | Peter Miele was appointed as our Vice President, Secretary and Director on January 6, 2012 and our Chief Financial Officer on April 13, 2012, and has served as Quest’s Executive Vice President and Director since the company’s inception in October 2008. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Outstanding Equity Awards at Fiscal Year-End |
|----------------------------------------------|
| Name                                         | Number of Securities Underlying Unexercised Options Exercisable (1) | Option Exercise Price($) | Option Expiration Date |
| John Balanko                                 | 1,750,000 | 0.90 | May 30, 2015 |
| Peter Miele                                  | 1,750,000 | 0.90 | May 30, 2015 |

| (1) | These options vested on the grant date of May 30, 2012. |
|-----|---------------------------------------------------------|

| ●   | the buy-out of any outstanding stock options of Quest for a price equal to the fair market value of the company’s common stock multiplied by the number of shares under options and less the exercise price thereof; plus |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | the greater of (i) the aggregate remaining base fees for the unexpired remainder of the term or (ii) one annual base fee plus one month of base fee for each year, or portion thereof, served after October 3, 2011. |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

| Title of Class                             | Name and Address of Beneficial Owner                                                   | Amount and Nature of Beneficial Ownership | Percent of Class (1) |
|--------------------------------------------|---------------------------------------------------------------------------------------------|----------------------------------------------------------|----------------------|
| Common  Stock                         | John Balanko (2)2030 Marine Drive, Suite 302North Vancouver, British ColumbiaCanada V7P 1V7 | 19,150,000 (3)                                           | 22.0                 |
| Common  Stock                         | Peter Miele (4)2030 Marine Drive, Suite 302North Vancouver, British ColumbiaCanada V7P 1V7  | 19,550,000 (5)                                           | 22.5                 |
| Common Stock                               | Josh Morita (6)3285 Blazer Parkway, Suite 200Lexington, Kentucky 40509                      | -                                                        | -                    |
| Common Stock                               | Dr. Laura Justice Sloan (7)3285 Blazer Parkway, Suite 200Lexington, Kentucky 40509          | -                                                        | -                    |
| All Officers and Directors as a Group | 38,700,000                                                                                  | 44.5                                                     |
| Series A Voting Preferred Stock (8)   | John Balanko (2)2030 Marine Drive, Suite 302North Vancouver, British ColumbiaCanada V7P 1V7 | 1                                                        | 50                   |
| Series A Voting Preferred Stock (8)   | Peter Miele (3)2030 Marine Drive, Suite 302North Vancouver, British ColumbiaCanada V7P 1V7  | 1                                                        | 50                   |
| All Officers and Directors as a Group | 2                                                                                           | 100                                                      |

| (1) | Based on 85,182,360 issued and outstanding shares of our common stock as of April 15, 2013. |
|-----|---------------------------------------------------------------------------------------------|

| (2) | John Balanko was appointed as our Chairman, President, Chief Executive Officer and director on January 6, 2012. |
|-----|-----------------------------------------------------------------------------------------------------------------|

| (3) | Includes 17,400,000 shares of our common stock and options to purchase 1,750,000 shares of our common stock at an exercise price of $0.90 per share until May 30, 2015. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Peter Miele was appointed as our Vice President, Secretary and director on January 6, 2012, and as our Chief Financial Officer on April 13, 2012. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Includes 17,400,000 shares of our common stock and options to purchase 1,750,000 shares of our common stock at an exercise price of $0.90 per share until May 30, 2015 owned by Peter Miele directly, and 400,000 shares of our common stock owned by Anne Marie Miele, the spouse of Mr. Miele. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | Josh Morita was our Chairman, President, Chief Executive Officer and director from our inception on February 25, 2010 to January 6, 2012. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | Dr. Laura Justice Sloan was our director from our inception on February 25, 2010 to January 6, 2012. |
|-----|------------------------------------------------------------------------------------------------------|

| (8) | Each holder of our Series A Voting Preferred Stock is entitled to the number of votes equal to the quotient derived by dividing the total number of outstanding shares of Series A Voting Preferred Stock into a number equal to the quotient derived by dividing 0.4285 into the total number of votes of our common stock and any other capital stock of the Company (other than the Series A Voting Preferred Stock) having general voting rights. Holders of Series A Voting Preferred Stock are entitled to vote on all matters on which the holders of our common stock are entitled to vote. The holders of shares of our common stock and the holders of shares of any other capital stock of the Company having general voting rights shall vote together as one class on all matters submitted to a vote of our stockholders. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Plan Category                     | Number of Securities to be Issued upon  Exercise of Outstanding Options, Warrants and Rights(a) | Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights(b) | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))(c) |
|----------------------------------------|----------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------|
| Plans approved by security holders     | -                                                                                                              | -                                                                              | -                                                                                                                                              |
| Plans not approved by security holders | 2,708,000 (1)                                                                                                  | 0.50                                                                           | -                                                                                                                                              |
| 5,050,000 (2)                          | 0.90                                                                                                           | 3,433,386 (3)                                                                  |

| (1) | Includes warrants to purchase 2,398,000 shares of our common stock at an exercise price of $0.50 per share until January 6, 2015 and warrants to purchase 310,000 shares of our common stock at an exercise price of $0.50 per share until February 10, 2015. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Includes options to purchase 5,050,000 shares of our common stock at an exercise price of $0.90 per share until May 30, 2015. |
|-----|-------------------------------------------------------------------------------------------------------------------------------|

| (3) | Represents unissued options to purchase shares of our common stock under the rolling 10% stock option plan we adopted on May 30, 2012. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------|

Item 13.  Certain Relationships and Related Transactions, and Director Independence

----

| ●   | the director is, or at any time during the past three years was, an employee of the company; |
|---------------------|----------------------------------------------------------------------------------------------|

| ●   | the director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including, among other things, compensation for board or board committee service); |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | a family member of the director is, or at any time during the past three years was, an executive officer of the company; |
|---------------------|--------------------------------------------------------------------------------------------------------------------------|

| ●   | the director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity to which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exclusions); |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three years, any of the executive officers of the company served on the compensation committee of such other entity; or |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | the director or a family member of the director is a current partner of the company’s outside auditor, or at any time during the past three years was a partner or employee of the company’s outside auditor, and who worked on the company’s audit. |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

Item 14.  Principal Accountant Fees and Services

|                              |   | Year EndedDecember 31, 2012($) |   |   | Year EndedDecember 31,2011($) |   |
|-----------------------------------|--------|--------------------------------|--------|--------|-------------------------------|--------|
| Audit fees and audit-related fees |   | 20,000                         |   |   |                          | 54,500 |   |
| Tax fees                          |   |                           | -      |   |                          |   | - |   |
| All other fees                    |   |                           | -      |   |                          |   | - |   |
| Total                             |   | 20,000                         |   |   |                          | 54,500 |   |

----

PART IV

Item 15.  Exhibits

| Exhibit Number | Description of Exhibit                                                                                                                                                                               |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1            | Share Exchange Agreement dated January 6, 2012 with Josh Morita, Quest Water Solutions, Inc. and the shareholders of Quest Water Solutions, Inc. (1)                                                 |
| 3.1            | Articles of Incorporation (2)                                                                                                                                                                        |
| 3.2            | Bylaws (2)                                                                                                                                                                                           |
| 3.3            | Certificate of Designation for Series A Voting Preferred Stock filed with the Delaware Secretary of State on December 29, 2011 (1)                                                                   |
| 3.4            | Certificate of Amendment filed with the Delaware Secretary of State on February 21, 2012 (3)                                                                                                         |
| 10.1           | Agreement of Sale dated January 6, 2012 with Josh Morita (1)                                                                                                                                         |
| 10.2           | Subscription Agreement dated January 6, 2012 (1)                                                                                                                                                     |
| 10.3           | Form of Warrant dated January 6, 2012 (1)                                                                                                                                                            |
| 10.4           | Registration Rights Agreement dated January 6, 2012 (1)                                                                                                                                              |
| 10.5           | Form of Lock-Up Agreement dated January 6, 2012 (1)                                                                                                                                                  |
| 10.6(a)        | Lock-Up/Leak Out Agreement with John Balanko dated January 6, 2012 (1)                                                                                                                               |
| 10.6(b)        | Lock-Up/Leak Out Agreement with Peter Miele dated January 6, 2012 (1)                                                                                                                                |
| 10.7           | Management Agreement with John Balanko dated November 1, 2011 (1)                                                                                                                                    |
| 10.8           | Management Agreement with Peter Miele dated November 1, 2011 (1)                                                                                                                                     |
| 10.9           | Global Cooperation Partner Agreement between Quest Water Solutions, Inc. and Trunz Water Systems AG, dated June 29, 2011 (1)                                                                         |
| 31.1           | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2           | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1           | Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                        |
| 32.2           | Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                        |
| 99.1           | Audit Committee Charter (4)                                                                                                                                                                          |

| (1) | Incorporated by reference from our Current Report on Form 8-K filed with the SEC on January 10, 2012. |
|-----|-------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference from our Registration Statement on Form S-1 filed with the SEC on August 17, 2010. |
|-----|--------------------------------------------------------------------------------------------------------------|

| (3) | Incorporated by reference from our Current Report on Form 8-K filed with the SEC on March 7, 2012. |
|-----|----------------------------------------------------------------------------------------------------|

| (4) | Incorporated by reference from our Annual Report on Form 10-K filed with the SEC on April 16, 2012. |
|-----|-----------------------------------------------------------------------------------------------------|

----

SIGNATURES

|  Date: April 15, 2013 | QUEST WATER GLOBAL, INC. |
|----------------------------|--------------------------|
|                       |                     |   |
|                       | By:                      | /s/ John Balanko  |
|                       |                     | John Balanko  |
|                       |                     | Chairman, President, Chief Executive Officer, Director |

| SIGNATURE         |   | TITLE                                                        |   | DATE           |
|-------------------|--------|--------------------------------------------------------------|--------|----------------|
|              |   |                                                         |   |           |
|              |   |                                                         |   |           |
| /s/ John Balanko  |   | Chairman, President, Chief Executive Officer, Director       |   | April 15, 2013 |
| John Balanko      |   |                                                         |   |           |
|              |   |                                                         |   |           |
|              |   |                                                         |   |           |
| /s/ Peter Miele   |   | Vice President, Chief Financial Officer, Secretary, Director |   | April 15, 2013 |
| Peter Miele  |   |                                                         |   |           |